Skip to Content

Arformoterol Pregnancy and Breastfeeding Warnings

Arformoterol is also known as: Brovana

Medically reviewed on Dec 26, 2017

Arformoterol Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

US FDA pregnancy category: C

Animal studies have shown teratogenicity at higher than clinically used doses. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Arformoterol Breastfeeding Warnings

Studies conducted in rats have shown excretion in breast milk resulting in increased death rate of pups.

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Yes

Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Brovana (arformoterol)." Sepracor Inc, Marlborough, MA.

References for breastfeeding information

  1. "Product Information. Brovana (arformoterol)." Sepracor Inc, Marlborough, MA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.